Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-03-13Clinical Trial Update: Entecavir for Biological Agents Associated HBV Reactivation in Inflammatory Arthritis Patients [Phase 4]
Phase 4 trial updating entecavir use for preventing hepatitis B reactivation in patients with inflammatory arthritis undergoing biological a…
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: Efficacy and Safety of Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF)-Containing Regimens in Participants With Chronic Hepatitis B Virus (HBV) Infection and Stage 2 or Greater Chronic Kidney Disease Who Have Received a Liver Transplant [Phase 2]
Phase 2 trial comparing Tenofovir Alafenamide (TAF) to TDF-containing regimens in chronic hepatitis B patients with stage 2+ chronic kidney …
-
CLINICAL_TRIALS trial_result · 2019-02-20Clinical Trial Update: Bioequivalence Study of Entecavir Tablets and Baraclude® Under Fasting Condition in Chinese Healthy Volunteers [NA]
The document reports completion of a fasting-state bioequivalence study comparing Entecavir tablets to Baraclude in healthy Chinese voluntee…
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: Tenofovir in Chronic Hepatitis B With Mild ALT Elevation [Phase 4]
Phase 4 clinical trial evaluating Tenofovir in chronic hepatitis B patients with mild ALT elevation has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-01Clinical Trial Update: A Study to Evaluate Persistence of Hepatitis B Antibodies, Immunogenicity and Safety of Engerix™-B Kinder Challenge Dose, in Adolescents Vaccinated With Four Doses of Infanrix™ Hexa During Infancy [Phase 4]
Phase 4 trial assessing persistence of Hepatitis B antibodies, immunogenicity, and safety of Engerix-B in adolescents previously vaccinated …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-02-01Clinical Trial Update: Prevalence of Hepatitis B in Vallés Occidental. Observational Multicentric Study
A multicenter observational study completed to determine the prevalence of Hepatitis B in Vallés Occidental.
-
CLINICAL_TRIALS trial_result · 2019-01-31Clinical Trial Update: Hepatitis B Vaccine for Non-responders [Phase 2]
Phase 2 trial update for a Hepatitis B vaccine in non-responders; the study has completed.
-
CLINICAL_TRIALS trial_result · 2019-01-31Clinical Trial Update: Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV . [Phase 3]
Phase 3 clinical trial evaluating an intensified re-vaccination schedule for hepatitis B in people with HIV; the study has completed.
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: Treatment Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in naïve Chronic Hepatitis B
This completed trial reports on the efficacy and safety of tenofovir disoproxil fumarate in treatment-naïve chronic hepatitis B patients. Th…
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: Strategies for the Prevention of Hepatitis B Among HIV Infected Patients in Uganda [Phase 4]
Phase 4 clinical trial update describing strategies to prevent Hepatitis B among HIV-infected individuals in Uganda.
-
CLINICAL_TRIALS trial_result · 2019-01-22Clinical Trial Update: Prophylactic or Preemptive Entecavir in Patients With Colorectal Cancer Who Are Inactive Hepatitis B Carriers [Phase 2]
Phase 2 trial update examining prophylactic or preemptive entecavir in colorectal cancer patients who are inactive hepatitis B carriers.
-
CLINICAL_TRIALS trial_result · 2019-01-15Clinical Trial Update: The Optimizing Treatment of Peginterferon Alpha in Chronic Hepatitis B Patients With Low Level HBsAg [Phase 4]
Phase 4 clinical trial update on optimizing peginterferon alpha treatment in chronic hepatitis B patients with low-level HBsAg.
-
CLINICAL_TRIALS trial_result · 2019-01-15Clinical Trial Update: The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAg [Phase 4]
Phase 4 clinical trial update for PegIFN Alfa in HBeAg-negative chronic hepatitis B patients with low level HBsAg.
-
CLINICAL_TRIALS trial_result · 2019-01-15Clinical Trial Update: The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAg [Phase 4]
Phase 4 trial update evaluating PegIFN alfa optimization in HBeAg-negative chronic hepatitis B patients with low level HBsAg; status current…
-
CLINICAL_TRIALS trial_result · 2019-01-04Clinical Trial Update: Development of Read-outs in Healthy, Hepatitis B Virus Naive Adults Vaccinated With the Hepatitis B Surface Antigen (HBsAg) in Combination With a GlaxoSmithKline (GSK) Biologicals' Adjuvant System [Phase 2]
Phase 2 trial update on a Hepatitis B vaccine regimen using HBsAg with GSK adjuvant system in healthy, HBV-naive adults; study status comple…
-
CLINICAL_TRIALS trial_result · 2019-01-04Clinical Trial Update: Lowering Viral Load With Nucleos(T)Ide Analogues Prior to Peginterferon Treatment to Ncrease Sustained Response in CHB [Phase 4]
Phase 4 clinical trial evaluating nucleos(t)ide analogues before peginterferon to increase sustained response in chronic hepatitis B has com…
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: Renoprotective Effects of Telbivudine in Chronic Hepatitis B [Phase 4]
A Phase 4 clinical trial assessing renoprotective effects of telbivudine in chronic hepatitis B patients is completed.
-
CLINICAL_TRIALS trial_result · 2018-11-29Clinical Trial Update: Safety and Immunogenicity of HBAI20 Hepatitis B Vaccine in Naive Adults and Non-responders [Phase 1]
Phase 1 trial assessing safety and immunogenicity of HBAI20 Hepatitis B Vaccine in naive adults and non-responders; results posted after com…
-
CLINICAL_TRIALS trial_result · 2018-11-05Clinical Trial Update: Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept [Phase 4]
Phase 4 trial comparing Telbivudine vs Tenofovir in HBeAg-negative chronic hepatitis B; results posted.
-
CLINICAL_TRIALS trial_result · 2018-10-03Clinical Trial Update: Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc [Phase 4]
Phase 4 clinical trial evaluating factors influencing immune response to combined Hepatitis A & B vaccine vs monovalent vaccines; completed …
-
CLINICAL_TRIALS trial_result · 2018-09-25Clinical Trial Update: A Study of ARC-521 Injection in Normal Adult Volunteers and Patients With Chronic Hepatitis B (CHB) [Phase 1]
Phase 1 study of ARC-521 in healthy adult volunteers and patients with chronic hepatitis B was terminated; results were posted on 2018-09-25…
-
CLINICAL_TRIALS trial_result · 2018-09-24Clinical Trial Update: TDF and LdT in Immune-tolerant CHB Patients Awaiting Assisted Reproduction [Phase 1, Phase 2]
Phase 1/2 trial update on TDF and LdT in immune-tolerant chronic hepatitis B patients awaiting assisted reproduction has completed.
-
CLINICAL_TRIALS trial_result · 2018-09-19Clinical Trial Update: Study to Evaluate the Antiviral Efficacy, Safety and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Pediatric Participants With Chronic Hepatitis B Infection [Phase 3]
Phase 3 trial in pediatric patients compares tenofovir disoproxil fumarate to placebo for chronic hepatitis B; results were posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-09-19Clinical Trial Update: Myrcludex B vs Entecavir in Patients With HBeAg Negative Chronic Hepatitis B [Phase 1, Phase 2]
Clinical trial comparing Myrcludex B to Entecavir in HBeAg-negative chronic hepatitis B has completed phases 1 and 2 with posted results.
-
CLINICAL_TRIALS trial_result · 2018-09-17Clinical Trial Update: Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m [Phase 3]
Phase 3 trial update of Tritanrix-HepB/Hib-MenAC and Mencevax ACWY vaccines with completed status and results posted in 2018.